Pilz S, Kienreich K, Rutters F, de Jongh R, van Ballegooijen AJ, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep 2013;13:261–70.Google Scholar
Lee S, Clark SA, Gill RK, Christakos S. 1,25-Dihydroxyvitamin D3 and pancreatic β-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinol 1994;134:1602–10.Google Scholar
Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, et al. Relationship between insulin resistance and plasma vitamin D in adults. Diabetes Metab Syndr Obes 2014;7:297–303.Google Scholar
Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, et al. Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010;33:1379–81.Web of ScienceGoogle Scholar
Reis JP, von Mühlen D, Miller ER 3rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009;124:e371–9.CrossrefGoogle Scholar
Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call for action from the American Diabetes Association and the American Heart Association. Circulation 2006;113:2943–6.Google Scholar
Sakou I-I, Psaltopoulou T, Sergentanis TN, Karavanaki K, Karachaliou F, et al. Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach. J Pediatr Endocrinol Metab 2015;28:589–96.Web of ScienceGoogle Scholar
Levy-Marchal C, Arslain S, Cutfield W, Sinaiko A, Druet C, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocr Metab 2010;95:5189–98.Google Scholar
Group of China Obesity Task Force. The body mass index reference norm for screening overweight and obesity in Chinese children and adolescents. Chin J Epidemiol 2004;25:97–102. (in Chinese).Google Scholar
Committee to Review Dietary Reference Intakes for Vitamin D and Calcium of Food and Nutrition Board of Institute of Medicine of National Academies. DRI dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press, 2011:13–14.Google Scholar
Challa AS, Makariou SE, Siomou EC. The relation of vitamin D status with metabolic syndrome in childhood and adolescence: an update. J Pediatr Endocrinol Metab 2015;28:1235–45.Web of ScienceGoogle Scholar
Rajakumar K, Heras JD, Lee SJ, Holick MF, Arslanian SA. 25-Hydroxyvitamin D concentrations and in vivo insulin sensitivity and β-cell function relative to insulin sensitivity in black and white youth. Diabetes Care 2012;35:627–33.Web of ScienceGoogle Scholar
Lee DY, Kwon AR, Ahn JM, Kim YJ, Chae HW, et al. Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008–2010. Ann Pediatr Endocrinol Metab 2015;20:46–52.Google Scholar
Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, et al. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. the Tromsø Study. PLoS One 2012;7:e37295.Web of ScienceGoogle Scholar
Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, et al. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004; 89–90:121–125.Google Scholar
Maestro B, Davila N, Carranza MC, Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003;84:223–30.Google Scholar
Maestro B, Molero S, Bajo S, D’avila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct 2002;20:227–32.Google Scholar
Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, et al. The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol 2005;349:248–60.Google Scholar
About the article
Published Online: 2016-04-18
Published in Print: 2016-07-01
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.